Synaptotagmin-2 Controls Regulated Exocytosis but Not Other Secretory Responses of Mast Cells
Ernestina Melicoff(The University of Texas MD Anderson Cancer Center), Roberto Adachi(The University of Texas MD Anderson Cancer Center), Alejandra Gomez‐Cadena(Pontificia Universidad Javeriana), Youlia Petrova(The University of Texas MD Anderson Cancer Center), Leticia Sansores-García(The University of Texas MD Anderson Cancer Center), Ruth Heidelberger(The University of Texas Health Science Center at Houston), Pratima Thakur(The University of Texas Health Science Center at Houston), Burton F. Dickey(The University of Texas MD Anderson Cancer Center), Proleta Datta(The University of Texas Health Science Center at Houston), Daniel C. Moreira(St. Jude Children's Research Hospital), Jayasimha N. Murthy(The University of Texas MD Anderson Cancer Center), Tanya Siddiqi(City Of Hope National Medical Center)
Cited by 51
Related Papers
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200–dependent pathway in mice
|Journal of Clinical Investigation|2011|197
The Mast Cell-restricted Tryptase mMCP-6 Has a Critical Immunoprotective Role in Bacterial Infections
|Journal of Biological Chemistry|2007|179
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.
|PubMed|2020|143
Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study
|The Lancet Child & Adolescent Health|2021|134